Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Replaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the study locations.
    Difference
    0.0%
    Check dated 2026-03-25T20:19:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T12:13:16.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Study status updated to Completed with new completion/actual dates; the previous Active, not recruiting status was removed.
    Difference
    0.1%
    Check dated 2026-02-18T03:28:35.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government funding lapse notice was removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T02:13:11.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A site-wide government funding status notice has been added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-03T22:34:29.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata labels, including a new 'Last Update Submitted that Met QC Criteria' entry and revision to v3.4.0, with capitalization changes for 'No FEAR Act Data'.
    Difference
    0.1%
    Check dated 2026-01-27T21:16:26.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.